Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Myocardial Infarction

glucose, (beta-d)-isomer has been researched along with Myocardial Infarction in 75 studies

Research

Studies (75)

TimeframeStudies, this research(%)All Research%
pre-19902 (2.67)18.7374
1990's1 (1.33)18.2507
2000's5 (6.67)29.6817
2010's32 (42.67)24.3611
2020's35 (46.67)2.80

Authors

AuthorsStudies
Breyer, RM; Ji, Y; Kong, D; Lazarus, M; Liu, G; Lu, A; Nakamura, M; Shen, Y; Stratakis, CA; Yu, Y; Zuo, S1
Kus, M; Tanda, K; Williams, FM; Williams, TJ1
Frank, P; Kieffer, L; Lévy, A1
Bessette, LG; Brodovicz, KG; Déruaz-Luyet, A; Glynn, RJ; Najafzadeh, M; Paik, JM; Patorno, E; Pawar, A; Schneeweiss, S; Wexler, DJ1
Brand, SB; Kansal, AR; Koitka-Weber, A; Kuti, E; Pfarr, E; Reifsnider, OS; Stargardter, M; Ustyugova, A; Wang, C; Wanner, C1
Andres, AM; Germano, JF; Gottlieb, RA; Huang, C; Mentzer, RM; Sin, J; Song, Y; Taylor, DJR; Thakur, R1
Aylward, P; Bhatt, DL; Cahn, A; Dalby, AJ; Dellborg, M; Dimulescu, D; Furtado, RHM; Gause-Nilsson, I; Goodrich, EL; Langkilde, AM; Leiter, LA; McGuire, DK; Mosenzon, O; Murphy, SA; Nicolau, JC; Oude Ophuis, AJM; Raz, I; Sabatine, MS; Wilding, JPH; Wiviott, SD1
Anker, SD; Bhatt, DL; Butler, J; Harrington, J; Hernandez, AF; Jones, WS; Petrie, MC; Sumin, M; Udell, JA; Vedin, O; Zwiener, I1
Chen, X; Fan, ZG; Ji, MY; Ma, GS; Xu, Y1
Liu, Z; Zhang, H1
Bhatt, DL; Cahn, A; Dwyer, JP; Fredriksson, M; Gause-Nilsson, IAM; Goodrich, EL; Heerspink, HJL; Johansson, PA; Langkilde, AM; Leiter, LA; McGuire, DK; Mosenzon, O; Murphy, SA; Raz, I; Rozenberg, A; Sabatine, MS; Schechter, M; Wilding, JPH; Wiviott, SD; Yanuv, I; Zelniker, TA1
Chen, F; Deng, R; Jiang, K; Liang, J; Lu, Y; Miao, Y; Qian, J; Shen, L; Su, F; Wang, D; Xiang, Y1
Anker, S; Butler, J; Harrington, J1
Ji, Y; Sun, L; Wang, FF; Yan, XJ; Zhang, JL; Zhu, Y1
Chen, F; Chen, K; Hwa, J; Jiang, K; Qian, J; Wang, D; Wang, H; Wu, Y; Xiang, Y; Xu, Y; Yang, B; Yu, Y; Zhou, C1
Alexander, J; Fukumitsu, M; Kawada, T; Li, M; Matsushita, H; Nishiura, A; Saku, K; Uemura, K; Yokota, S; Yoshida, Y1
Bergenstal, RM; Fitchett, D; George, JT; Hantel, S; Inzucchi, SE; Kaspers, S; Kiš, SG; Monteiro, P; Toural, E; Zinman, B1
Li, Y; Lin, X; Tong, L; Wu, F; Wu, X; Wu, Y; Ye, B1
Li, J; Li, X; Liu, J; Lu, Q; Ren, D; Sun, X; Tong, N; Zhang, J1
Hirose, M; Ibi, M; Ishida, N; Matsushita, N; Morino, Y; Saito, M; Sawa, Y; Taira, E1
Chen, P; Han, B; Liu, J; Ruan, H; Wu, P; Yimei, D; Zhang, M1
Ablasser, K; Alber, H; Berger, R; Kaulfersch, C; Kolesnik, E; Leitner, K; Lichtenauer, M; Mader, A; Moertl, D; Oulhaj, A; Pferschy, PN; Reiter, C; Rieder, T; Saely, CH; Sailer, S; Siller-Matula, J; Sourij, H; Tripolt, NJ; Verheyen, N; von Lewinski, D; Weidinger, F; Zechner, PM1
Advani, A; Batchu, SN; Connelly, KA; Desjardins, JF; Gilbert, RE; Kabir, G; Nghiem, L; Thai, K; Visram, A; Yerra, VG; Zhang, Y1
de Boer, RA; de Menezes Montenegro, L; Heerspink, HJL; Hillebrands, JL; Oberdorf-Maass, SU; Silljé, HHW; van Goor, H; Westenbrink, BD; Yurista, SR1
Brueckmann, M; Butler, J; Fitchett, D; George, JT; Inzucchi, SE; Mazer, CD; Ofstad, AP; Sharma, A; Verma, S; Wanner, C; Zinman, B; Zwiener, I1
Kimura, Y; Kuno, A; Miki, T; Miura, T; Mizuno, M; Moniwa, N; Oshima, H; Sato, T; Tanaka, M; Tanno, M; Yano, T1
Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A1
Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Jaiwongkam, T; Kerdphoo, S; Lahnwong, S; Palee, S; Sriwichaiin, S1
Badimon, JJ; Garcia-Ropero, A; Ishikawa, K; Picatoste, B; Requena-Ibanez, JA; Santos-Gallego, CG; Sanz, J; Tunon, J; Vargas-Delgado, AP1
Asensio Lopez, MDC; Bayes-Genis, A; Fernandez Del Palacio, MJ; Hernandez Vicente, A; Hernandez-Martinez, A; Lax, A; Pascual Figal, DA; Saura Guillen, E1
Hu, NB; Jin, P; Li, LH; Shi, Y1
Dibrov, E; Kura, B; Netticadan, T; O'Hara, KA; Parikh, M; Pierce, GN; Slezak, J1
Asai, K; Hoshika, Y; Ishikawa, M; Iwasaki, YK; Kodani, E; Kubota, Y; Maruyama, M; Miyamoto, M; Miyauchi, Y; Mozawa, K; Ogano, M; Shimizu, W; Takano, H; Tanabe, J; Tara, S; Tokita, Y; Tsukada, Y; Yamamoto, T; Yodogawa, K1
George, JT; Hantel, S; Koitka-Weber, A; Levin, A; Perkovic, V; von Eynatten, M; Wanner, C; Wheeler, DC1
Kang, L; Liu, Y; Wu, M; Xu, B; Xu, J1
Abdel-Kareem, MA; Ahmed, AS; Elsisy, RA; Mona, MM1
Bøtker, HE; Hansen, J; Hjortbak, MV; Jespersen, NR; Kvist, F; Lassen, TR; Seefeldt, JM1
Atar, S; Bandel, N; Daud, E; Ertracht, O; Moady, G; Reuveni, T; Shehadeh, M1
Chen, SY; Chen, WT; Lee, CC; Lee, TM1
Asai, K; Hoshika, Y; Iwasaki, YK; Kodani, E; Kubota, Y; Maruyama, M; Miyamoto, M; Miyauchi, Y; Mozawa, K; Shimizu, W; Takano, H; Tanabe, J; Tara, S; Tokita, Y; Tsukada, Y; Yamamoto, T; Yodogawa, K1
Cheng, KK; Ghosh, S; Gokhale, K; Hanif, W; Kumarendran, B; Marshall, T; Narendran, P; Nirantharakumar, K; Thomas, GN; Toulis, KA; Willis, BH1
Chilton, RJ1
Das, S; Devkar, R; Jana, S; Mandal, R; Patel, D; Patel, S; Thadani, J; Upadhyay, K1
Grewal, G; Kirby, C; McCallum, JL; Netticadan, T; Raj, P; Wigle, JT; Yu, L1
Chattipakorn, N; Chattipakorn, SC; Sa-Nguanmoo, P; Siri-Angkul, N; Sivasinprasasn, S; Tanajak, P; Thummasorn, S1
Chen, H; Dong, Y; He, X; Li, J; Wang, J1
Kimura, Y; Kuno, A; Miki, T; Miura, T; Mizuno, M; Nakata, K; Oshima, H; Sato, T; Tanno, M; Yano, T1
Connelly, KA; Desjardins, JF; Gilbert, RE; Thai, K; Zhang, Y1
Cao, D; Chen, G; Guo, D; Jin, M; Liu, G; Yuan, X1
Abe, K; Kimura, Y; Kuno, A; Miki, T; Miura, T; Mizuno, M; Nakata, K; Ohwada, W; Oshima, H; Sato, T; Tanno, M; Yano, T1
Baartscheer, A; Buchholtz, N; Coronel, R; Eerbeek, O; Hollmann, MW; Nederlof, R; Schumacher, C; Uthman, L; Weber, NC; Zuurbier, CJ1
Bhatt, DL; Bonaca, MP; Cahn, A; Fredriksson, M; Furtado, RHM; Gause-Nilsson, IAM; Kuder, J; Langkilde, AM; Leiter, LA; McGuire, DK; Mosenzon, O; Murphy, SA; Nicolau, JC; Raz, I; Ruff, CT; Sabatine, MS; Wilding, JPH; Wiviott, SD; Zelniker, TA1
de Boer, RA; Hillebrands, JL; Oberdorf-Maass, SU; Pavez Giani, MG; Schouten, EM; Silljé, HHW; van Goor, H; van Veldhuisen, DJ; Westenbrink, BD; Yurista, SR1
Polovina, MM; Seferović, JP; Seferović, PM1
Austria, JA; Garg, B; Netticadan, T; Parikh, M; Pierce, GN; Raj, P; Yu, L1
Packer, M1
Gilinsky, MA; Komarova, NI; Latysheva, TV; Naumenko, SE; Rogachev, AD; Salakhutdinov, NF; Tolstikov, GA1
Alperin, P; Cohen, M; Dziuba, J; Goswami, D; Grossman, HL; Hardy, E; Iloeje, U; Perlstein, I; Racketa, J1
Chen, C; Gao, J; Gao, Y; Guo, J; Wang, H; Wu, R1
Chen, C; Du, P; Wang, J1
Du, G; Liu, Y; Ren, M; Tian, J; Wang, X1
Stiefelhagen, P1
Duan, W; Hua, F; Li, H; Song, F; Sun, J; Wang, S; Xie, Y; Yan, L; Yang, Q; Zhou, X1
Duan, J; Guo, Y; Hou, L; Hu, J; Lin, J; Man, W; Shen, M; Sun, D; Wang, H; Zhang, D; Zhang, M; Zhang, Y; Zhao, Z1
George, J; Kaku, K; Kaspers, S; Lee, J; Mattheus, M; Woerle, HJ1
Chang, NC; Lee, TM; Lin, SZ1
Hong, D; Wu, L; Yang, J; Yang, X; Yu, J; Zeng, X1
Ao, H; Gao, XF; Shi, HM; Sun, T1
Jiang, WL; Liu, HZ; Tang, XX; Zhang, SM1
Fan, R; He, J; Huang, X; Liu, Z; Qin, F; Ren, P; Tang, T; Wang, Y; Zhang, C; Zhang, H; Zhou, H; Zhu, Z1
Hou, J; Jiang, WL; Kang, ZC; Xu, Y; Zhu, HB1
Koneru, S; Maulik, N; Penumathsa, SV; Prasad, K; Thirunavukkarasu, M; Zhan, L1
John, S; Koneru, S; Maulik, N; Menon, VP; Penumathsa, SV; Prasad, K; Zhan, L1
Cui, F; Wang, YP; Yang, CY; Zhang, LP; Zhang, Y1
Bokarev, IN; Golikov, AP; Lusov, VA; Ptushkin, VV; Savenkov, MP; Seregina, MV; Zvereva, TV1

Trials

13 trial(s) available for glucose, (beta-d)-isomer and Myocardial Infarction

ArticleYear
Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2022, Volume: 79, Issue:6

    Topics: Aged; Benzhydryl Compounds; Cardiovascular Diseases; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucose; Glucosides; Heart Failure; Humans; Hypoglycemic Agents; Medicare; Myocardial Infarction; United States

2022
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.
    Circulation, 2022, 05-24, Volume: 145, Issue:21

    Topics: Acute Kidney Injury; Aged; Benzhydryl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glucosides; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Sodium-Glucose Transporter 2 Inhibitors

2022
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial.
    American heart journal, 2022, Volume: 253

    Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosides; Heart Failure; Humans; Myocardial Infarction; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Ventricular Dysfunction, Left

2022
Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial.
    Diabetes care, 2022, 10-01, Volume: 45, Issue:10

    Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rate; Glucose; Glucosides; Humans; Myocardial Infarction; Sodium; Sodium-Glucose Transporter 2 Inhibitors

2022
Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial.
    Age and ageing, 2019, 11-01, Volume: 48, Issue:6

    Topics: Aged; Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Stroke

2019
Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial.
    American heart journal, 2020, Volume: 221

    Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Double-Blind Method; Echocardiography; Glucosides; Glycated Hemoglobin; Heart Failure; Hospitalization; Humans; Ketone Bodies; Length of Stay; Mortality; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Sodium-Glucose Transporter 2 Inhibitors

2020
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial.
    Diabetes, obesity & metabolism, 2020, Volume: 22, Issue:7

    Topics: Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucosides; Heart Failure; Hospitalization; Humans; Myocardial Infarction; Risk Factors; Thrombolytic Therapy

2020
Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial.
    Cardiovascular diabetology, 2020, 09-25, Volume: 19, Issue:1

    Topics: 3-Iodobenzylguanidine; Aged; Benzhydryl Compounds; Blood Pressure; Body Weight; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Double-Blind Method; Electrocardiography, Ambulatory; Female; Glucosides; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Parasympathetic Nervous System; Radionuclide Imaging; Radiopharmaceuticals; Sodium-Glucose Transporter 2 Inhibitors; Sympathetic Nervous System; Uric Acid

2020
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories:
    Clinical journal of the American Society of Nephrology : CJASN, 2020, 10-07, Volume: 15, Issue:10

    Topics: Adams-Stokes Syndrome; Aged; Albuminuria; Benzhydryl Compounds; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Genital Diseases, Female; Genital Diseases, Male; Glomerular Filtration Rate; Glucosides; Heart Failure; Hospitalization; Humans; Infections; Male; Middle Aged; Mortality; Myocardial Infarction; Placebos; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors

2020
Effect of Empagliflozin Versus Placebo on Body Fluid Balance in Patients With Acute Myocardial Infarction and Type 2 Diabetes Mellitus: Subgroup Analysis of the EMBODY Trial.
    Journal of cardiac failure, 2022, Volume: 28, Issue:1

    Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Heart Failure; Humans; Myocardial Infarction; Prospective Studies; Water-Electrolyte Balance

2022
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
    Circulation, 2019, 05-28, Volume: 139, Issue:22

    Topics: Aged; Benzhydryl Compounds; Brain Ischemia; Cause of Death; Diabetes Mellitus, Type 2; Disease Progression; Double-Blind Method; Female; Glucosides; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk Assessment; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Stroke; Time Factors; Treatment Outcome

2019
[Empagliflozin improves cardiovascular prognosis].
    MMW Fortschritte der Medizin, 2016, Mar-17, Volume: 158, Issue:5

    Topics: Benzhydryl Compounds; Cause of Death; Diabetes Complications; Diabetes Mellitus, Type 2; Germany; Glucosides; Humans; Hypoglycemic Agents; Myocardial Infarction; Survival Rate

2016
Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease - Results From EMPA-REG OUTCOME
    Circulation journal : official journal of the Japanese Circulation Society, 2017, Jan-25, Volume: 81, Issue:2

    Topics: Aged; Asian People; Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Stroke; Treatment Outcome

2017

Other Studies

62 other study(ies) available for glucose, (beta-d)-isomer and Myocardial Infarction

ArticleYear
PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.
    The Journal of experimental medicine, 2016, 09-19, Volume: 213, Issue:10

    Topics: Animals; Cecum; Cell Polarity; Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit; Disease Models, Animal; Female; Gene Deletion; Hydantoins; Inflammation; Janus Kinase 2; Ligation; Macrophages; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Ischemia; Peritonitis; Prostaglandin D2; Protein Binding; Protein Subunits; Punctures; Receptors, Immunologic; Receptors, Interferon; Receptors, Prostaglandin; Signal Transduction; STAT1 Transcription Factor; Wound Healing; Zymosan

2016
Trimetazidine inhibits neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits.
    Journal of cardiovascular pharmacology, 1993, Volume: 22, Issue:6

    Topics: Animals; Blood Pressure; Capillary Permeability; Disease Models, Animal; Heart Rate; Interleukin-8; Leukotriene B4; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophils; Rabbits; Trimetazidine; Zymosan

1993
[Disorders in left ventricle repolarization during acute cytosteatonecrotic pancreatitis. Electrocardiographic course under the effect of antienzymes].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1969, Feb-26, Volume: 45, Issue:10

    Topics: Acute Disease; Adult; Amylases; Cardiomyopathies; Electrocardiography; Heart Conduction System; Humans; Hyperlipidemias; Ischemia; Lipase; Liver Function Tests; Male; Myocardial Infarction; Pancreas; Pancreatitis; Zymosan

1969
Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.
    Diabetes, obesity & metabolism, 2022, Volume: 24, Issue:3

    Topics: Adult; Aged; Benzhydryl Compounds; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucosides; Humans; Medicare; Middle Aged; Myocardial Infarction; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; United States

2022
Attenuation of Adverse Postinfarction Left Ventricular Remodeling with Empagliflozin Enhances Mitochondria-Linked Cellular Energetics and Mitochondrial Biogenesis.
    International journal of molecular sciences, 2021, Dec-31, Volume: 23, Issue:1

    Topics: Animals; Benzhydryl Compounds; Electrocardiography; Energy Metabolism; Glucosides; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Mitophagy; Myocardial Infarction; Organelle Biogenesis; Ubiquitin-Protein Ligases; Ventricular Remodeling

2021
Appropriate Dose of Dapagliflozin Improves Cardiac Outcomes by Normalizing Mitochondrial Fission and Reducing Cardiomyocyte Apoptosis After Acute Myocardial Infarction.
    Drug design, development and therapy, 2022, Volume: 16

    Topics: Animals; Apoptosis; Benzhydryl Compounds; Glucosides; Mitochondrial Dynamics; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley

2022
Effects of Dapagliflozin in Combination with Metoprolol Sustained-Release Tablets on Prognosis and Cardiac Function in Patients with Acute Myocardial Infarction after PCI.
    Computational and mathematical methods in medicine, 2022, Volume: 2022

    Topics: Benzhydryl Compounds; Biomarkers; C-Reactive Protein; Delayed-Action Preparations; Drug Therapy, Combination; Glucosides; Humans; Interleukin-6; Metoprolol; Myocardial Infarction; Percutaneous Coronary Intervention; Prognosis; Serum Albumin; Stroke Volume; Superoxide Dismutase; Tablets; Ventricular Function, Left

2022
Novel cardioprotective mechanism for Empagliflozin in nondiabetic myocardial infarction with acute hyperglycemia.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 154

    Topics: Animals; Beclin-1; Benzhydryl Compounds; Glucosides; Hyperglycemia; Mice; Myocardial Infarction; Sodium-Glucose Transporter 2 Inhibitors

2022
Putting the puzzle together: SGLT2 inhibitors from prevention to treatment of heart failure.
    European heart journal, 2022, 11-01, Volume: 43, Issue:41

    Topics: Glucosides; Heart Failure; Humans; Myocardial Infarction; Sodium-Glucose Transporter 2 Inhibitors

2022
Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Cardiovascular diabetology, 2022, 09-16, Volume: 21, Issue:1

    Topics: Benzhydryl Compounds; Glucose; Glucosides; Heart Failure; Humans; Myocardial Infarction; Neprilysin; Percutaneous Coronary Intervention; Prognosis; Receptors, Angiotensin; Retrospective Studies; Triglycerides

2022
Bone marrow-derived naïve B lymphocytes improve heart function after myocardial infarction: a novel cardioprotective mechanism for empagliflozin.
    Basic research in cardiology, 2022, 09-28, Volume: 117, Issue:1

    Topics: Animals; B-Lymphocytes; Benzhydryl Compounds; Bone Marrow; Glucosides; Heart Failure; Immunoglobulin D; Immunoglobulin M; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Percutaneous Coronary Intervention; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Remodeling

2022
Acute effects of empagliflozin on open-loop baroreflex function and urinary glucose excretion in rats with chronic myocardial infarction.
    The journal of physiological sciences : JPS, 2023, Sep-13, Volume: 73, Issue:1

    Topics: Animals; Baroreflex; Glucose; Glucosides; Myocardial Infarction; Rats

2023
Paeoniflorin on Rat Myocardial Ischemia Reperfusion Injury of Protection and Mechanism Research.
    Pharmacology, 2020, Volume: 105, Issue:5-6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cardiotonic Agents; Caspase 3; Glucosides; Male; MAP Kinase Signaling System; Medicine, Chinese Traditional; Monoterpenes; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley

2020
Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway.
    Molecular and cellular endocrinology, 2020, 02-05, Volume: 501

    Topics: AMP-Activated Protein Kinases; Animals; Benzhydryl Compounds; Cell Hypoxia; Glucosides; Ischemia; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Signal Transduction

2020
Pretreatment with KGA-2727, a selective SGLT1 inhibitor, is protective against myocardial infarction-induced ventricular remodeling and heart failure in mice.
    Journal of pharmacological sciences, 2020, Volume: 142, Issue:1

    Topics: Animals; Fibrosis; Gene Expression Regulation; Glucosides; Heart Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Pyrazoles; RNA, Messenger; Sodium-Glucose Transporter 1; Ventricular Remodeling

2020
Protective effects of Salidroside on cardiac function in mice with myocardial infarction.
    Scientific reports, 2019, 12-02, Volume: 9, Issue:1

    Topics: Animals; Apoptosis; Cardiotonic Agents; Coronary Vessels; Cytokines; Disease Models, Animal; Fibrosis; Glucosides; Heart; Ligation; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Phenols; Ventricular Remodeling

2019
Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction.
    Cardiovascular diabetology, 2020, 02-08, Volume: 19, Issue:1

    Topics: Animals; Benzhydryl Compounds; Calcium Signaling; Disease Models, Animal; Glucosides; Heart Failure; Myocardial Infarction; Myocardium; Rats, Inbred F344; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Ventricular Function, Left; Ventricular Pressure

2020
Effects of Sodium-Glucose Co-transporter 2 Inhibition with Empaglifozin on Renal Structure and Function in Non-diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction.
    Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:3

    Topics: Animals; Benzhydryl Compounds; Biomarkers; Disease Models, Animal; Diuresis; Glucosides; Kidney; Male; Myocardial Infarction; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Function, Left

2020
Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats.
    Scientific reports, 2020, 04-29, Volume: 10, Issue:1

    Topics: Acute Kidney Injury; Animals; Benzhydryl Compounds; Diabetes Complications; Diabetes Mellitus, Experimental; Glucosides; Kidney; Male; Myocardial Infarction; Rats

2020
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:9

    Topics: Animals; Benzhydryl Compounds; Bisoprolol; Cardiovascular Agents; Chronic Disease; Disease Models, Animal; Exercise Tolerance; Fosinopril; Glucosides; Heart Failure; Male; Myocardial Infarction; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Spironolactone; Ventricular Dysfunction, Left; Ventricular Function, Left

2020
Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury.
    Cardiovascular diabetology, 2020, 06-15, Volume: 19, Issue:1

    Topics: Animals; Apoptosis; Arrhythmias, Cardiac; Benzhydryl Compounds; Disease Models, Animal; Energy Metabolism; Glucosides; Male; Mitochondria, Heart; Mitochondrial Dynamics; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Function, Left

2020
Correlation between myocardial strain and adverse remodeling in a non-diabetic model of heart failure following empagliflozin therapy.
    Expert review of cardiovascular therapy, 2020, Volume: 18, Issue:9

    Topics: Animals; Benzhydryl Compounds; Glucosides; Heart Failure; Humans; Myocardial Infarction; Myocardium; Sodium-Glucose Transporter 2 Inhibitors; Swine; Ventricular Function, Left

2020
Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status.
    Scientific reports, 2020, 08-11, Volume: 10, Issue:1

    Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Glucosides; GTP Cyclohydrolase; Male; Myocardial Infarction; Rats; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Remodeling

2020
Salidroside inhibits apoptosis and autophagy of cardiomyocyte by regulation of circular RNA hsa_circ_0000064 in cardiac ischemia-reperfusion injury.
    Gene, 2021, Jan-30, Volume: 767

    Topics: Animals; Apoptosis; Autophagy; Gene Expression Regulation; Glucosides; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Phenols; Plant Extracts; Rats; Rats, Wistar; Reperfusion Injury; Rhodiola; RNA, Circular; Superoxide Dismutase

2021
Cardioprotective Effects of Dietary Flaxseed Post-Infarction Are Associated with Changes in MicroRNA Expression.
    Biomolecules, 2020, 09-08, Volume: 10, Issue:9

    Topics: alpha-Linolenic Acid; Animal Feed; Animals; Butylene Glycols; Collagen Type I; Disease Models, Animal; Fatty Acids; Flax; Glucosides; Homeodomain Proteins; Male; MicroRNAs; Myocardial Infarction; Rats, Sprague-Dawley; Seeds; Up-Regulation

2020
Empagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic mice.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2021, Jun-01, Volume: 161

    Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus; Glucosides; Humans; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocytes, Cardiac

2021
SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 139

    Topics: Acute Kidney Injury; Animals; Benzhydryl Compounds; Cell Adhesion Molecules; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Electrocardiography; Glucosides; Kidney; Lipocalin-2; Male; Myocardial Infarction; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Sodium-Glucose Transporter 2 Inhibitors

2021
Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats.
    Scientific reports, 2021, 05-05, Volume: 11, Issue:1

    Topics: Animals; Benzhydryl Compounds; Cardiotonic Agents; Glucosides; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors

2021
The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats.
    Cardiovascular diabetology, 2021, 07-02, Volume: 20, Issue:1

    Topics: Animals; Benzhydryl Compounds; Collagen; Disease Models, Animal; Fibrosis; Glucosides; Hydroxyproline; Male; Myocardial Infarction; Myocardium; Rats, Sprague-Dawley; Smad3 Protein; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Time Factors; Transforming Growth Factor beta1; Ventricular Function, Left

2021
Dapagliflozin attenuates arrhythmic vulnerabilities by regulating connexin43 expression via the AMPK pathway in post-infarcted rat hearts.
    Biochemical pharmacology, 2021, Volume: 192

    Topics: AMP-Activated Protein Kinases; Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Connexin 43; Gene Expression; Glucosides; Male; Myocardial Infarction; Rats; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Remodeling

2021
All-Cause Mortality in Patients With Diabetes Under Treatment With Dapagliflozin: A Population-Based, Open-Cohort Study in The Health Improvement Network Database.
    The Journal of clinical endocrinology and metabolism, 2017, 05-01, Volume: 102, Issue:5

    Topics: Aged; Benzhydryl Compounds; Cardiovascular Diseases; Case-Control Studies; Cause of Death; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Female; Glucosides; Heart Failure; Humans; Hypoglycemic Agents; Ischemic Attack, Transient; Male; Middle Aged; Mortality; Myocardial Infarction; Myocardial Ischemia; Retrospective Studies; Stroke; Ventricular Dysfunction, Left

2017
Introduction.
    The American journal of cardiology, 2017, 07-01, Volume: 120, Issue:1S

    Topics: Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucosides; Heart Failure; Hospitalization; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Secondary Prevention; Sodium-Glucose Transporter 2 Inhibitors; Stroke

2017
Anthocyanin rich extract of Brassica oleracea L. alleviates experimentally induced myocardial infarction.
    PloS one, 2017, Volume: 12, Issue:8

    Topics: Animals; Animals, Newborn; Anthocyanins; Antioxidants; Apoptosis; Brassica; Caveolin 3; Gene Expression Profiling; Glucosides; Humans; Hydrogen Peroxide; Isoproterenol; Male; Molecular Docking Simulation; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Plant Extracts; Rats; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases

2017
Effects of cyanidin 3-0-glucoside on cardiac structure and function in an animal model of myocardial infarction.
    Food & function, 2017, Nov-15, Volume: 8, Issue:11

    Topics: Animals; Anthocyanins; Disease Models, Animal; Glucosides; Heart; Humans; Male; Myocardial Infarction; Myocardium; Oryza; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley

2017
Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury.
    The Journal of endocrinology, 2018, Volume: 236, Issue:2

    Topics: Animals; Benzhydryl Compounds; Cardiotonic Agents; Cytoprotection; Diet, High-Fat; Glucosides; Heart; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Ventricular Dysfunction, Left; Ventricular Function, Left; Vildagliptin

2018
Paeoniflorin improves cardiac function and decreases adverse postinfarction left ventricular remodeling in a rat model of acute myocardial infarction.
    Drug design, development and therapy, 2018, Volume: 12

    Topics: Acute Disease; Animals; Apoptosis; Disease Models, Animal; Glucosides; Heart Function Tests; Male; Monoterpenes; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Remodeling

2018
Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts.
    Physiological reports, 2018, Volume: 6, Issue:12

    Topics: Animals; Autophagy; Benzhydryl Compounds; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosides; Male; Microscopy, Electron; Mitochondria, Heart; Mitochondrial Proteins; Mitochondrial Size; Myocardial Infarction; Myocytes, Cardiac; Rats, Inbred OLETF; Reactive Oxygen Species; Sodium-Glucose Transporter 2 Inhibitors; Triglycerides; Vacuoles

2018
Dual inhibition of sodium-glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction.
    Cardiovascular diabetology, 2018, 07-07, Volume: 17, Issue:1

    Topics: Animals; Benzhydryl Compounds; Carbonates; Disease Models, Animal; Glucosides; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Myocardium; Rats, Inbred F344; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2018
Polydatin protects against acute myocardial infarction-induced cardiac damage by activation of Nrf2/HO-1 signaling.
    Journal of natural medicines, 2019, Volume: 73, Issue:1

    Topics: Acute Disease; Animals; Apoptosis; Drugs, Chinese Herbal; Glucosides; Humans; Male; Myocardial Infarction; Myocytes, Cardiac; NF-E2-Related Factor 2; Protective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Stilbenes

2019
Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats.
    The Journal of pharmacology and experimental therapeutics, 2019, Volume: 368, Issue:3

    Topics: Animals; Antioxidants; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Male; Metabolome; Myocardial Infarction; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Sodium-Glucose Transporter 2 Inhibitors

2019
Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts.
    Cardiovascular research, 2019, Aug-01, Volume: 115, Issue:10

    Topics: Animals; Benzhydryl Compounds; Disease Models, Animal; Glucosides; Guanidines; Insulin; Isolated Heart Preparation; Male; Mice, Inbred C57BL; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Sodium-Hydrogen Exchanger 1; Sulfones; Time Factors

2019
Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction.
    European journal of heart failure, 2019, Volume: 21, Issue:7

    Topics: Animals; Benzhydryl Compounds; Echocardiography; Energy Metabolism; Glucosides; Heart Failure; Myocardial Infarction; Rats; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2019
Diving into the unknown: sodium-glucose cotransporter-2 inhibitors in heart failure without diabetes.
    European journal of heart failure, 2019, Volume: 21, Issue:7

    Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucose; Glucosides; Heart Failure; Myocardial Infarction; Rats; Sodium; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left

2019
Dietary flaxseed protects against ventricular arrhythmias and left ventricular dilation after a myocardial infarction.
    The Journal of nutritional biochemistry, 2019, Volume: 71

    Topics: alpha-Linolenic Acid; Animals; Arrhythmias, Cardiac; Body Weight; Butylene Glycols; Cardiotonic Agents; Dietary Supplements; Electrocardiography; Fatty Acids; Flax; Glucosides; Male; Myocardial Infarction; Myocarditis; Organ Size; Rats, Sprague-Dawley; Ventricular Remodeling

2019
Reconceptualization of the Molecular Mechanism by Which Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Events.
    Circulation, 2019, 08-06, Volume: 140, Issue:6

    Topics: Benzhydryl Compounds; Blood Volume; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Diuretics; Glucose; Glucosides; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; Multicenter Studies as Topic; Myocardial Infarction; Natriuresis; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sodium-Hydrogen Exchanger 1; Stroke; Stroke Volume

2019
Cardioprotective effect of resveratrol and resveratroloside.
    Cardiovascular & hematological agents in medicinal chemistry, 2013, Volume: 11, Issue:3

    Topics: Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; Glucosides; Infusions, Parenteral; Male; Myocardial Infarction; Rats; Rats, Wistar; Reference Standards; Resveratrol; Stilbenes; Treatment Outcome

2013
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes.
    Diabetes, obesity & metabolism, 2014, Volume: 16, Issue:7

    Topics: Amputation, Surgical; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Disease Progression; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incidence; Kidney Failure, Chronic; Metformin; Microcirculation; Middle Aged; Myocardial Infarction; Nutrition Surveys; Sodium-Glucose Transporter 2 Inhibitors; Stroke; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Uric Acid

2014
Cardioprotective effect of polydatin on ventricular remodeling after myocardial infarction in coronary artery ligation rats.
    Planta medica, 2015, Volume: 81, Issue:7

    Topics: Aldosterone; Animals; Antioxidants; Captopril; Collagen; Coronary Occlusion; Coronary Vessels; Endothelin-1; Glucosides; Heart Ventricles; Hydroxyproline; Hypertrophy; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Nitric Oxide; Phytotherapy; Plant Extracts; Polygonum; Rats, Sprague-Dawley; Renin-Angiotensin System; Stilbenes; Ventricular Remodeling

2015
Paeoniflorin ameliorates acute myocardial infarction of rats by inhibiting inflammation and inducible nitric oxide synthase signaling pathways.
    Molecular medicine reports, 2015, Volume: 12, Issue:3

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Caspase 3; Caspase 9; Creatine Kinase; Creatine Kinase, MB Form; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glucosides; Inflammation; L-Lactate Dehydrogenase; Medicine, Chinese Traditional; Monoterpenes; Myocardial Infarction; NF-kappa B; Nitric Oxide Synthase Type II; Paeonia; Rats; Rats, Sprague-Dawley; Signal Transduction; Troponin T

2015
Calycosin‑7‑O‑β‑D‑glucoside attenuates ischemia‑reperfusion injury in vivo via activation of the PI3K/Akt pathway.
    Molecular medicine reports, 2016, Volume: 13, Issue:1

    Topics: Animals; Apoptosis; Chromones; Creatine Kinase; Enzyme Activation; Glucosides; Isoflavones; L-Lactate Dehydrogenase; Male; Morpholines; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidative Stress; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction

2016
Cardiac stem cell transplantation with 2,3,5,4'-tetrahydroxystilbehe-2-O-β-d-glucoside improves cardiac function in rat myocardial infarction model.
    Life sciences, 2016, Aug-01, Volume: 158

    Topics: Animals; Disease Models, Animal; Glucosides; Heart Rate; Male; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation; Stilbenes

2016
Polydatin protects cardiomyocytes against myocardial infarction injury by activating Sirt3.
    Biochimica et biophysica acta. Molecular basis of disease, 2017, Volume: 1863, Issue:8

    Topics: Animals; Apoptosis; Disease Models, Animal; Glucosides; Mice; Mice, Knockout; Mitochondria, Heart; Myocardial Infarction; Myocytes, Cardiac; Organelle Biogenesis; Sirtuin 3; Stilbenes

2017
Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts.
    Free radical biology & medicine, 2017, Volume: 104

    Topics: Animals; Benzhydryl Compounds; Fibrosis; Gene Expression Regulation; Glucosides; Humans; Interleukin-10; Macrophages; Myocardial Infarction; Myocardium; Rats; Reactive Oxygen Species; Signal Transduction; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; STAT3 Transcription Factor

2017
Effect of Guanxin No.2 decoction on gene expression in different areas of the myocardial infarcted heart of rats using microarray technology.
    The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:2

    Topics: Animals; Benzaldehydes; Benzoates; Benzofurans; Bridged-Ring Compounds; Cardiotonic Agents; Carthamus tinctorius; Catechols; Chalcone; Coumaric Acids; Dalbergia; Drugs, Chinese Herbal; Gene Expression; Gene Expression Profiling; Glucosides; Heart Ventricles; Hydroxybenzoates; Lactates; Ligusticum; Male; Monoterpenes; Myocardial Infarction; Oligonucleotide Array Sequence Analysis; Paeonia; Plant Extracts; Quinones; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Salvia miltiorrhiza

2009
Effects of Radix et Rhizoma Rhodiolae Kirilowii on expressions of von Willebrand factor, hypoxia-inducible factor 1 and vascular endothelial growth factor in myocardium of rats with acute myocardial infarction.
    Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2009, Volume: 7, Issue:5

    Topics: Animals; Drugs, Chinese Herbal; Glucosides; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Myocardial Infarction; Myocardium; Phenols; Phytotherapy; Rats; Rats, Wistar; Rhizome; Rhodiola; RNA, Messenger; Vascular Endothelial Growth Factor A; von Willebrand Factor

2009
Protective roles of cornuside in acute myocardial ischemia and reperfusion injury in rats.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2011, Feb-15, Volume: 18, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cornus; Disease Models, Animal; Drugs, Chinese Herbal; Glucosides; Heart; Hemodynamics; Inflammation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phytotherapy; Plants, Medicinal; Pyrans; Rats; Rats, Sprague-Dawley

2011
A strategy for detecting optimal ratio of cardioprotection-dependent three compounds as quality control of guan-xin-er-hao formula.
    Journal of ethnopharmacology, 2011, Jan-27, Volume: 133, Issue:2

    Topics: Animals; Apoptosis; Benzaldehydes; Benzoates; Bridged-Ring Compounds; Cardiotonic Agents; Caspase 3; Catechols; Chalcone; Chemistry, Pharmaceutical; Coumaric Acids; Drugs, Chinese Herbal; Ethnopharmacology; Glucosides; Male; Monoterpenes; Myocardial Infarction; Phytotherapy; Quality Control; Quinones; Rats; Rats, Sprague-Dawley

2011
Cardioprotection with 8-O-acetyl shanzhiside methylester on experimental myocardial ischemia injury.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2012, Aug-30, Volume: 47, Issue:1

    Topics: Animals; Cardiotonic Agents; Cells, Cultured; Collagen; Glucosides; HMGB1 Protein; Hypoxia; Inflammation; Interleukin-6; Male; Myocardial Infarction; Myocardial Reperfusion Injury; NF-kappa B; Phosphorylation; Pyrans; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha

2012
Secoisolariciresinol diglucoside: relevance to angiogenesis and cardioprotection against ischemia-reperfusion injury.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 320, Issue:2

    Topics: Animals; Apoptosis; Butylene Glycols; Cells, Cultured; Echocardiography; Glucosides; Humans; Male; Morphogenesis; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Rats; Rats, Sprague-Dawley

2007
Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium.
    Journal of molecular and cellular cardiology, 2008, Volume: 44, Issue:1

    Topics: Animals; Blood Vessels; Blotting, Western; Butylene Glycols; Cardiotonic Agents; Coronary Vessels; Glucosides; Heart Function Tests; Heme Oxygenase-1; Hypercholesterolemia; Lipid Metabolism; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Phosphoproteins; Rats; Rats, Sprague-Dawley; Ultrasonography; Vascular Endothelial Growth Factor A

2008
Protective effect of polydatin against ischemia/reperfusion injury in rat heart.
    Sheng li xue bao : [Acta physiologica Sinica], 2008, Apr-25, Volume: 60, Issue:2

    Topics: Animals; Glucosides; Heart; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Stilbenes; Superoxide Dismutase

2008
Anturan for secondary prophylaxis of myocardial infarction.
    Folia haematologica (Leipzig, Germany : 1928), 1988, Volume: 115, Issue:4

    Topics: Adrenergic beta-Antagonists; Diuretics; Drug Therapy, Combination; Female; Glucosides; Humans; Male; Middle Aged; Myocardial Infarction; Sulfinpyrazone

1988